Clinical Trial Update: Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta

View source ↗

Summary

The longitudinal study of interferon beta in patients with clinically isolated syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome

Drugs mentioned

• Interferon-beta (interferon beta)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Clinically Isolated Syndrome | Status: TERMINATED